Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...
Pharmaceutical giants like Lilly and Nordisk are battling for dominance in India’s weight-loss market with price cuts and ...
Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...
A daily weight-loss pill will soon be available in the US, after the regulator gave approval to Danish drug company Novo ...
ZME Science on MSN
Obesity Patients Lost Nearly 30 percent of Their Body Weight on a New Experimental Drug and Many Saw Their Knee Pain Disappear
In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...
Dec 23 () - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo ...
Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat ...
Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity ...
Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...
The FDA has approved the first daily pill for obesity treatment, offering a new alternative to injectable weight loss drugs.
Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...
A blockbuster obesity drug made in the Triangle is fueling a global pharma company's multibillion-dollar expansion in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback